Eddingpharm’s purchase of Eli Lilly antibiotics business published by SAMR for simple case review
MLex Summary: The proposed acquisition by pharmaceutical products manufacturer Eddingpharm Group of US pharmaceutical company Eli Lilly and Co’s business related to two antibiotic medicines — cefaclor monohydrate and vancomycin hydrochloride — has...To view the full article, register now.
Already a subscriber? Click here to view full article